Buckner FS - Search Results

1

Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation.

Eastman RT, Buckner FS, Yokoyama K, Gelb MH, Van Voorhis WC. Eastman RT, et al. Among authors: buckner fs. J Lipid Res. 2006 Feb;47(2):233-40. doi: 10.1194/jlr.R500016-JLR200. Epub 2005 Dec 7. J Lipid Res. 2006. PMID: 16339110 Free article. Review.

2

Engineering cytokine secretion from Trypanosoma cruzi.

La Flamme AC, Buckner F, Swindle J, Ajioka J, Barrett L, Van Voorhis WC. La Flamme AC, et al. Mem Inst Oswaldo Cruz. 1994 Oct-Dec;89(4):650-1. doi: 10.1590/s0074-02761994000400025. Mem Inst Oswaldo Cruz. 1994. PMID: 8524068 Free article. No abstract available.

3

Trypanosoma cruzi: expression of interleukin-2 utilizing both supercoiled plasmids and linear DNAs.

La Flamme AC, Buckner FS, Swindle J, Ajioka J, Van Voorhis WC. La Flamme AC, et al. Among authors: buckner fs. Exp Parasitol. 1996 Jun;83(1):159-63. doi: 10.1006/expr.1996.0061. Exp Parasitol. 1996. PMID: 8654546 No abstract available.

4

Expression of mammalian cytokines by Trypanosoma cruzi indicates unique signal sequence requirements and processing.

La Flamme AC, Buckner FS, Swindle J, Ajioka J, Van Voorhis WC. La Flamme AC, et al. Among authors: buckner fs. Mol Biochem Parasitol. 1995 Dec;75(1):25-31. doi: 10.1016/0166-6851(95)02506-5. Mol Biochem Parasitol. 1995. PMID: 8720172

5

Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase.

Buckner FS, Verlinde CL, La Flamme AC, Van Voorhis WC. Buckner FS, et al. Antimicrob Agents Chemother. 1996 Nov;40(11):2592-7. doi: 10.1128/AAC.40.11.2592. Antimicrob Agents Chemother. 1996. PMID: 8913471 Free PMC article.

6

Trypanosoma cruzi: use of herpes simplex virus-thymidine kinase as a negative selectable marker.

Buckner FS, Wilson AJ, Van Voorhis WC. Buckner FS, et al. Exp Parasitol. 1997 Jul;86(3):171-80. doi: 10.1006/expr.1997.4163. Exp Parasitol. 1997. PMID: 9225767

7

Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.

Buckner FS, Wipke BT, Van Voorhis WC. Buckner FS, et al. Eur J Immunol. 1997 Oct;27(10):2541-8. doi: 10.1002/eji.1830271012. Eur J Immunol. 1997. PMID: 9368608

8

The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth.

Yokoyama K, Trobridge P, Buckner FS, Scholten J, Stuart KD, Van Voorhis WC, Gelb MH. Yokoyama K, et al. Among authors: buckner fs. Mol Biochem Parasitol. 1998 Jul 1;94(1):87-97. doi: 10.1016/s0166-6851(98)00053-x. Mol Biochem Parasitol. 1998. PMID: 9719512

9

Protein farnesyltransferase from Trypanosoma brucei. A heterodimer of 61- and 65-kda subunits as a new target for antiparasite therapeutics.

Yokoyama K, Trobridge P, Buckner FS, Van Voorhis WC, Stuart KD, Gelb MH. Yokoyama K, et al. Among authors: buckner fs. J Biol Chem. 1998 Oct 9;273(41):26497-505. doi: 10.1074/jbc.273.41.26497. J Biol Chem. 1998. PMID: 9756885 Free article.

10

Induction of resistance to azole drugs in Trypanosoma cruzi.

Buckner FS, Wilson AJ, White TC, Van Voorhis WC. Buckner FS, et al. Antimicrob Agents Chemother. 1998 Dec;42(12):3245-50. doi: 10.1128/AAC.42.12.3245. Antimicrob Agents Chemother. 1998. PMID: 9835521 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page